Editas Medicine Stock Forecast

Sell candidate since Jul 21, 2026

The Editas Medicine, Inc stock price gained 0.347% on the last trading day (Tuesday, 21st Jul 2026), rising from $2.88 to $2.89. During the last trading day the stock fluctuated 3.50% from a day low at $2.86 to a day high of $2.96. The price has fallen in 7 of the last 10 days and is down by -22.93% for this period. Volume fell on the last day by -249 thousand shares and in total, 1 million shares were bought and sold for approximately $3.31 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.22% during the next 3 months and, with a 90% probability hold a price between $2.52 and $3.93 at the end of this 3-month period.

EDIT Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has risen 0.347%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Editas Medicine, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $3.00 and $2.95. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Editas Medicine, Inc stock

Editas Medicine, Inc finds support from accumulated volume at $2.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.100 between high and low, or 3.50%. For the last week, the stock has had daily average volatility of 6.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EDIT) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Editas Medicine, Inc to open at $2.90, and during the day (based on 14 day Average True Range), to move between $2.77 and $3.01, which gives a possible trading interval of +/-$0.243 (+/-8.78%) up or down from last closing price. If Editas Medicine, Inc takes out the full calculated possible swing range there will be an estimated 8.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.85 (1.38%) than the resistance at $3.08 (6.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Editas Medicine, Inc stock A Buy?

The Editas Medicine, Inc stock holds several negative signals and despite the positive trend, we believe Editas Medicine, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.112 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 22, 2026 - $2.90 ( 0.346%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk